Trial intelligence / Profile preview

Amoxicillin vs benzathine penicillin G for early syphilis

jRCT1031210615Recruiting

Sponsor
National Center for Global Health and Medicine
Start
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial in syphilis comparing Amoxicillin + probenecid with Benzathine penicillin G (2 arms). Primary endpoint: Serological cure rate at 6 months. Started Feb 2022; status: recruiting.

02

Drugs

amoxicillinbenzathine penicillin G
03

Conditions

syphilis

Beyond the preview

Go deeper on jRCT1031210615.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1031210615.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call